Xalkori Interactions
There are 808 drugs known to interact with Xalkori (crizotinib), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 316 are major, 476 are moderate, and 16 are minor.
- View all 808 medications that may interact with Xalkori
- View Xalkori alcohol/food interactions (1)
- View Xalkori disease interactions (7)
Most frequently checked interactions
View interaction reports for Xalkori (crizotinib) and the medicines listed below.
- acetaminophen
- Alecensa (alectinib)
- allopurinol
- amlodipine
- Avastin (bevacizumab)
- benzonatate
- cetirizine
- clonazepam
- Compazine (prochlorperazine)
- Decadron (dexamethasone)
- dexamethasone
- diclofenac
- docusate
- duloxetine
- Eliquis (apixaban)
- ethambutol
- Fentanyl Transdermal System (fentanyl)
- Flexeril (cyclobenzaprine)
- fondaparinux
- furosemide
- gabapentin
- guaifenesin
- hydrocodone
- lorazepam
- omeprazole
- ondansetron
- rosuvastatin
- Tagrisso (osimertinib)
- Tarceva (erlotinib)
- Vitamin D3 (cholecalciferol)
Xalkori alcohol/food interactions
There is 1 alcohol/food interaction with Xalkori (crizotinib).
Xalkori disease interactions
There are 7 disease interactions with Xalkori (crizotinib) which include:
- bradycardia
- gastrointestinal perforation
- hepatic impairment
- ILD/pneumonitis
- QT prolongation
- renal impairment
- visual loss
Report options
QR code containing a link to this page
More about Xalkori (crizotinib)
- Xalkori consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
